Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ZTS Zoetis Inc
- Stocks
- Healthcare
- NYSE: ZTS
Price (delayed)
$154.96
Market cap
$68.99B
P/E Ratio
27.77
Dividend/share
$1.86
EPS
$5.58
Enterprise value
$74.02B
Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's
Highlights
The P/E is 29% lower than the 5-year quarterly average of 39.3 and 15% lower than the last 4 quarters average of 32.5
Zoetis's EPS has increased by 8% YoY and by 2% QoQ
Zoetis's quick ratio has decreased by 47% YoY and by 6% QoQ
ZTS's equity is down by 8% year-on-year and by 2.4% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Key stats
What are the main financial stats of ZTS
Market
Valuations
Earnings
Shares outstanding
445.21M
Market cap
$68.99B
Enterprise value
$74.02B
Price to earnings (P/E)
27.77
Price to book (P/B)
14.91
Price to sales (P/S)
7.47
EV/EBIT
21.73
EV/EBITDA
18.99
EV/Sales
7.97
Revenue
$9.29B
Gross profit
$6.59B
Operating income
$3.42B
Net income
$2.52B
EBIT
$3.41B
EBITDA
$3.9B
Free cash flow
$2.28B
Per share
Balance sheet
Liquidity
EPS
$5.58
EPS diluted
$5.57
Free cash flow per share
$5.1
Book value per share
$10.4
Revenue per share
$20.75
TBVPS
$23.01
Total assets
$14.1B
Total liabilities
$9.44B
Debt
$6.75B
Equity
$4.66B
Working capital
$2.49B
Debt to equity
1.45
Current ratio
1.74
Quick ratio
0.91
Net debt/EBITDA
1.29
Margins
Efficiency
Dividend
EBITDA margin
42%
Gross margin
70.9%
Net margin
27.1%
Operating margin
36.8%
Return on assets
17.7%
Return on equity
51.3%
Return on invested capital
26.7%
Return on capital employed
31.8%
Return on sales
36.7%
Dividend yield
1.2%
DPS
$1.86
Payout ratio
33.4%
ZTS stock price
How has the Zoetis stock price performed over time
Intraday
-2.42%
1 week
-2.65%
1 month
-6.84%
1 year
-12.82%
YTD
-4.89%
QTD
-0.63%
Financial performance
How have Zoetis's revenue and profit performed over time
Revenue
$9.29B
Gross profit
$6.59B
Operating income
$3.42B
Net income
$2.52B
Gross margin
70.9%
Net margin
27.1%
The gross profit has grown by 8% YoY
ZTS's revenue is up by 6% YoY
Zoetis's operating income has increased by 6% YoY
The net income has grown by 5% YoY
Price vs fundamentals
How does ZTS's price correlate with its fundamentals
Growth
What is Zoetis's growth rate over time
Valuation
What is Zoetis stock price valuation
P/E
27.77
P/B
14.91
P/S
7.47
EV/EBIT
21.73
EV/EBITDA
18.99
EV/Sales
7.97
The P/E is 29% lower than the 5-year quarterly average of 39.3 and 15% lower than the last 4 quarters average of 32.5
Zoetis's EPS has increased by 8% YoY and by 2% QoQ
The stock's price to book (P/B) is 17% less than its 5-year quarterly average of 18.0 and 7% less than its last 4 quarters average of 16.0
ZTS's equity is down by 8% year-on-year and by 2.4% since the previous quarter
ZTS's price to sales (P/S) is 27% lower than its 5-year quarterly average of 10.2 and 13% lower than its last 4 quarters average of 8.6
ZTS's revenue is up by 6% YoY
Efficiency
How efficient is Zoetis business performance
ZTS's ROIC is up by 9% YoY and by 4.3% QoQ
The company's return on equity rose by 6% YoY and by 3.2% QoQ
ZTS's return on assets is up by 4.7% year-on-year
Dividends
What is ZTS's dividend history
DPS
$1.86
Dividend yield
1.2%
Payout ratio
33.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Zoetis financials performed over time
ZTS's total assets is 49% greater than its total liabilities
The company's current ratio fell by 48% YoY
Zoetis's quick ratio has decreased by 47% YoY and by 6% QoQ
The debt is 45% higher than the equity
Zoetis's debt to equity has increased by 8% YoY and by 2.8% QoQ
ZTS's equity is down by 8% year-on-year and by 2.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.